REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
6.99
-0.85 (-10.79%)
Mar 31, 2025, 1:17 PM EDT - Market open
REGENXBIO Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$32.89
Upside
+370.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +386.76% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +386.76% | Mar 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +644.45% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +386.76% | Mar 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +644.45% | Mar 14, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +243.59% | Mar 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $38 → $14 | Strong Buy → Hold | Downgrades | $38 → $14 | +100.43% | Feb 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $30 | Buy | Reiterates | $30 | +329.49% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +415.39% | Jan 15, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +401.07% | Dec 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $36 | Strong Buy | Maintains | $40 → $36 | +415.39% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +644.45% | Nov 20, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $22 | Buy | Initiates | $22 | +214.96% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $39 → $40 | Strong Buy | Maintains | $39 → $40 | +472.66% | Nov 7, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +644.45% | Oct 22, 2024 |
| Raymond James | Raymond James | Buy Initiates $18 | Buy | Initiates | $18 | +157.70% | Oct 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.